De Novo Drug Design on GSK3b+QED alpha=0.2
97Observed Coverage
Unweighted
Updated 1mo ago
Evaluation Results
| Method | Links | |
|---|---|---|
2023.10 | 97 | |
2023.10 | 95 | |
2023.10 | 90 | |
2023.10 | 82 | |
2023.10 | 74 | |
2023.10 | 71 | |
2023.10 | 39 | |
2023.10 | 36 |
Unweighted
| Method | Links | |
|---|---|---|
2023.10 | 97 | |
2023.10 | 95 | |
2023.10 | 90 | |
2023.10 | 82 | |
2023.10 | 74 | |
2023.10 | 71 | |
2023.10 | 39 | |
2023.10 | 36 |